Literature DB >> 24172572

Central retinal arterial occlusion (CRAO) after phacoemulsification-a rare complication.

G Lamichhane, P Gautam.   

Abstract

BACKGROUND: While peribulbar anesthesia is generally safe, a remote risk of retinal vascular accident exists and its routine use should be done with caution.
OBJECTIVE: To report a case of central retinal artery occlusion (CRAO) that occurred within 24 hours of routine uneventful phacoemulsification cataract surgery using peribulbar anesthesia. We share our experience of a 45-year old man who underwent uneventful clear corneal temporal incision phacoemulsification cataract surgery using peribulbar lignocain injection with adrenaline. CASE: A Patient who underwent routine phacoemulsification surgery of left eye for posterior sub-capsular cataract under peribulbar anesthesia developed central retinal artery occlusion in the immediate post-operative period. The surgery was uneventful.
CONCLUSION: Central retinal artery occlusion is a rare but dreadful complication seen after uneventful phacoemulsification and the cause is mainly due to anesthesia related. © NEPjOPH.

Entities:  

Mesh:

Year:  2013        PMID: 24172572     DOI: 10.3126/nepjoph.v5i2.8746

Source DB:  PubMed          Journal:  Nepal J Ophthalmol        ISSN: 2072-6805


  3 in total

1.  Iatrogenic central retinal artery occlusion following retrobulbar anesthesia with adrenaline for vitreoretinal surgery: a case report.

Authors:  Filippo Confalonieri; Gunn Elin Ladstein; Ingar Stene-Johansen; Goran Petrovski
Journal:  J Med Case Rep       Date:  2022-08-09

2.  Profound vascular stasis of retina and optic nerve following retrobulbar anesthesia.

Authors:  Bozho Todorich; Paul Hahn
Journal:  Int Med Case Rep J       Date:  2016-04-29

3.  Central retinal artery occlusion on postoperative day one after vitreoretinal surgery.

Authors:  Jonathan F Russell; Nathan L Scott; Luis J Haddock; Alexander M Eaton; Harry W Flynn
Journal:  Am J Ophthalmol Case Rep       Date:  2018-10-05
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.